Form 4: NICE Ltd. VP Acquires 5,000 Stock Options
Insider Transaction Report
Udi Yehuda Dayan, VP of Corporate Finance at NICE Ltd., acquired 5,000 stock options with an exercise price of $0.3211, vesting over four years.
Summary
- Udi Yehuda Dayan, VP of Corporate Finance at NICE Ltd., acquired 5,000 derivative securities in the form of stock options.
- The options have an exercise price of $0.3211 per share.
- The options will vest in substantially equal installments on April 1, 2027, April 1, 2028, April 1, 2029, and April 1, 2030.
- The expiration date for these options is April 1, 2032.
- Following this transaction, Udi Yehuda Dayan beneficially owns 5,000 derivative securities directly.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive event for corporate governance and executive alignment, as it ties a key executive's incentives to the company's long-term stock performance.
Positives
- The grant of stock options to a key executive like the VP of Corporate Finance aligns management's interests with long-term shareholder value creation.
Negatives
- No direct negatives for the company's operational performance are indicated in this filing.
Risks
- No specific risks related to company operations or financial health are mentioned in this Form 4 filing, which primarily reports insider transactions.
Future Outlook
The vesting schedule for the acquired stock options extends through April 1, 2030, indicating a long-term incentive structure for the executive.
Industry Context
StockSavvy.ai notes that the granting of stock options is a common practice in the technology and software industry, including companies like NICE Ltd., to incentivize and retain key executives. This aligns with typical compensation strategies seen across competitors in the enterprise software and customer experience markets.
Comparison to Industry Standards
- The use of stock options as a component of executive compensation is a standard practice across the technology sector, comparable to compensation structures at companies like Salesforce, Oracle, or SAP.
- The multi-year vesting schedule (four years) is typical for executive equity grants, designed to promote long-term commitment and performance, similar to plans observed at peer companies.
Stakeholder Impact
- Shareholders: Potential dilution upon exercise of options, but also increased alignment of executive interests with shareholder value.
- Employees: May signal confidence in the company's future and standard executive compensation practices.
Next Steps
- The stock options will vest in substantially equal installments on April 1, 2027, April 1, 2028, April 1, 2029, and April 1, 2030.
- The options can be exercised at any time after vesting until their expiration on April 1, 2032.
Key Dates
| Date | Description |
|---|---|
| 04/01/2026 | Date of earliest transaction for stock option acquisition. |
| 04/01/2027 | First vesting installment date for stock options. |
| 04/01/2028 | Second vesting installment date for stock options. |
| 04/01/2029 | Third vesting installment date for stock options. |
| 04/01/2030 | Fourth and final vesting installment date for stock options. |
| 04/01/2032 | Expiration date for stock options. |
Keywords
NICE Ltd., NICE, Form 4, Insider Trading, Stock Options, Executive Compensation, Udi Yehuda Dayan, Corporate Finance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.